UBS Group’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $539K | Buy |
42,084
+4,675
| +12% | +$59.9K | ﹤0.01% | 4781 |
|
|
2025
Q1 | $475K | Sell |
37,409
-30,755
| -45% | -$390K | ﹤0.01% | 4712 |
|
|
2024
Q4 | $894K | Buy |
68,164
+17,878
| +36% | +$235K | ﹤0.01% | 4289 |
|
|
2024
Q3 | $758K | Sell |
50,286
-6,770
| -12% | -$102K | ﹤0.01% | 3800 |
|
|
2024
Q2 | $808K | Buy |
57,056
+14,749
| +35% | +$209K | ﹤0.01% | 3571 |
|
|
2024
Q1 | $577K | Buy |
42,307
+5,363
| +15% | +$73.1K | ﹤0.01% | 3994 |
|
|
2023
Q4 | $497K | Sell |
36,944
-6,961
| -16% | -$93.7K | ﹤0.01% | 3977 |
|
|
2023
Q3 | $547K | Sell |
43,905
-4,268
| -9% | -$53.2K | ﹤0.01% | 3544 |
|
|
2023
Q2 | $652K | Buy |
48,173
+2,117
| +5% | +$28.7K | ﹤0.01% | 3620 |
|
|
2023
Q1 | $642K | Sell |
46,056
-6,211
| -12% | -$86.5K | ﹤0.01% | 3527 |
|
|
2022
Q4 | $743K | Sell |
52,267
-11,696
| -18% | -$166K | ﹤0.01% | 3366 |
|
|
2022
Q3 | $874K | Sell |
63,963
-18,300
| -22% | -$250K | ﹤0.01% | 2950 |
|
|
2022
Q2 | $1.17M | Sell |
82,263
-27,029
| -25% | -$385K | ﹤0.01% | 2775 |
|
|
2022
Q1 | $1.81M | Sell |
109,292
-12,524
| -10% | -$207K | ﹤0.01% | 2737 |
|
|
2021
Q4 | $2.34M | Buy |
121,816
+4,093
| +3% | +$78.7K | ﹤0.01% | 2748 |
|
|
2021
Q3 | $2.45M | Buy |
117,723
+2,973
| +3% | +$61.8K | ﹤0.01% | 2603 |
|
|
2021
Q2 | $2.46M | Sell |
114,750
-6,818
| -6% | -$146K | ﹤0.01% | 2577 |
|
|
2021
Q1 | $2.4M | Buy |
121,568
+16,784
| +16% | +$331K | ﹤0.01% | 2610 |
|
|
2020
Q4 | $2.07M | Buy |
104,784
+5,414
| +5% | +$107K | ﹤0.01% | 2609 |
|
|
2020
Q3 | $1.75M | Buy |
99,370
+6,516
| +7% | +$115K | ﹤0.01% | 2508 |
|
|
2020
Q2 | $1.67M | Buy |
92,854
+60,333
| +186% | +$1.08M | ﹤0.01% | 2421 |
|
|
2020
Q1 | $487K | Sell |
32,521
-1,561
| -5% | -$23.4K | ﹤0.01% | 3226 |
|
|
2019
Q4 | $594K | Buy |
34,082
+12,457
| +58% | +$217K | ﹤0.01% | 3752 |
|
|
2019
Q3 | $326K | Sell |
21,625
-663
| -3% | -$10K | ﹤0.01% | 4022 |
|
|
2019
Q2 | $375K | Sell |
22,288
-1,715
| -7% | -$28.9K | ﹤0.01% | 3723 |
|
|
2019
Q1 | $411K | Buy |
24,003
+3,075
| +15% | +$52.7K | ﹤0.01% | 3466 |
|
|
2018
Q4 | $316K | Sell |
20,928
-1,917
| -8% | -$28.9K | ﹤0.01% | 3796 |
|
|
2018
Q3 | $466K | Sell |
22,845
-18,220
| -44% | -$372K | ﹤0.01% | 3691 |
|
|
2018
Q2 | $772K | Sell |
41,065
-5,580
| -12% | -$105K | ﹤0.01% | 3243 |
|
|
2018
Q1 | $896K | Buy |
46,645
+2,580
| +6% | +$49.6K | ﹤0.01% | 3106 |
|
|
2017
Q4 | $865K | Sell |
44,065
-23,729
| -35% | -$466K | ﹤0.01% | 3111 |
|
|
2017
Q3 | $1.46M | Buy |
67,794
+13,022
| +24% | +$280K | ﹤0.01% | 2717 |
|
|
2017
Q2 | $1.14M | Sell |
54,772
-8,072
| -13% | -$168K | ﹤0.01% | 2814 |
|
|
2017
Q1 | $1.22M | Sell |
62,844
-7,253
| -10% | -$141K | ﹤0.01% | 2705 |
|
|
2016
Q4 | $1.19M | Buy |
70,097
+10,825
| +18% | +$184K | ﹤0.01% | 2692 |
|
|
2016
Q3 | $1.11M | Sell |
59,272
-15,212
| -20% | -$285K | ﹤0.01% | 2665 |
|
|
2016
Q2 | $1.28M | Buy |
74,484
+11,252
| +18% | +$194K | ﹤0.01% | 2525 |
|
|
2016
Q1 | $1.13M | Sell |
63,232
-35,859
| -36% | -$643K | ﹤0.01% | 2562 |
|
|
2015
Q4 | $2.34M | Buy |
99,091
+21,273
| +27% | +$503K | ﹤0.01% | 2068 |
|
|
2015
Q3 | $1.75M | Sell |
77,818
-20,893
| -21% | -$470K | ﹤0.01% | 2241 |
|
|
2015
Q2 | $2.79M | Sell |
98,711
-8,731
| -8% | -$246K | ﹤0.01% | 2052 |
|
|
2015
Q1 | $2.96M | Buy |
107,442
+27,567
| +35% | +$760K | ﹤0.01% | 2003 |
|
|
2014
Q4 | $1.99M | Buy |
+79,875
| New | +$1.99M | ﹤0.01% | 2250 |
|